Spark Therapeutics Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Spark Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Spark Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | -2.260% | -3.623% | 10.833% | 121.667% | 60.241% | 336.066% | 176.968% |
| United Therapeutics | 1.070% | -2.337% | 0.000% | 82.424% | 9.548% | 121.010% | 198.153% |
| Ionis Pharmaceuticals Inc. | -1.560% | -6.782% | -26.469% | 30.767% | -30.018% | 26.928% | 53.568% |
News
Palantir's Wild Ride: Inside the Stock Wall Street Can't Agree On
Key Points
- Interested in Palantir Technologies Inc.? Here are five stocks we like better.
- Palantir Technologies continues to post exceptional revenue growth, led by U.S. government and commercial
Dollar Tree’s Turnaround Is Starting to Take Root
Key Points
- Interested in Dollar Tree, Inc.? Here are five stocks we like better.
- Dollar Tree's board approved a $2.5 billion share repurchase in July 2026, arriving shortly after activist
ERock IPO: A $1.3B Power Play Solution
Key Points
- Interested in Eaton Corporation, PLC? Here are five stocks we like better.
- ERock completed a highly anticipated initial public offering to accelerate the expansion of its primary